Verition Fund Management LLC Ark Genomic Revolution ETF (De Transaction History

Verition Fund Management LLC

$21.7 Billion
Q3 2025

A detailed history of Verition Fund Management LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Verition Fund Management LLC holds 100,000 shares of ARKG stock, worth $2.69 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

100,000

Holding current value

$2.69 Million

% of portfolio

0.08%

0 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form

No transaction found.

Others Institutions Holding ARKG

# of Institutions

297

Shares Held

20.3M

Call Options Held

2.53M

Put Options Held

2.8M

Jpmorgan Chase & CO New York, NY

3.94M
Shares

$106 Million
0.01% of portfolio
Morgan Stanley New York, NY

2.83M
Shares

$76.2 Million
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

2.16M
Shares

$58.1 Million
0.01% of portfolio
Citigroup Inc

1.52M
Shares

$40.8 Million
0.02% of portfolio
Ubs Group Ag

1.12M
Shares

$30.1 Million
0.01% of portfolio

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Ark Genomic Revolution ETF (De Transaction History